SCHEMBL17504062

SCHEMBL17504062

[O-][S+](Cc1nccs1)C(c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 3/20 0.49
▸ KDM1A O60341 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ PDPK1 O15530 1/20 0.36
▸ OPRL1 P41146 1/20 0.35
▸ CTSA P10619 1/20 0.35
▸ FDPS P14324 1/20 0.34
▸ NR1H3 Q13133 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ SCN1A P35498 1/20 0.33
▸ SCN1B Q07699 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17504058 0.76 POLB (0.39) SLC6A3NPC1RAB9ALMNANR3C1
SCHEMBL31570743 0.73 SLC6A3 (0.57) SLC6A3KDM1AMAOBNPC1RAB9A
SCHEMBL21462611 0.73 SLC6A3 (0.32) SLC6A3
SCHEMBL5798292 0.72 TRPA1 (0.39) SLC6A3TSHR
SCHEMBL18984985 0.70 SLC6A3 (0.36) SLC6A3
SCHEMBL17504073 0.70 SLC6A3 (0.51) SLC6A3CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8034456 0.69 GRIN2D (0.53) SLC6A3KDM1AMAOBPDPK1OPRL1
SCHEMBL30380236 0.69 SLC6A3 (0.53) SLC6A3KDM1AMAOBPDPK1FDPS
SCHEMBL8722436 0.69 GRIN2D (0.53) SLC6A3KDM1AMAOBPDPK1OPRL1
SCHEMBL21456809 0.69 SLC6A3 (0.50) SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3553053-A1 (S)-ENANTIOMERIC FORM OF A HETEROCYCLIC COMPOUND HAVING MOTIVATION IMPROVING AND/OR REFERENCE MEMORY ENHANCING ACTIVITY Red Bull GmbH (AT) 2019-10-16 — — EP claimed
US-10221147-B2 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2019-03-05 — — US claimed
EP-2985279-B1 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2017-08-02 — — EP claimed
US-20170174642-A1 HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY COGMOTIV FLEXCO (AT) 2017-06-22 — — US claimed
EP-2985279-A1 Heterocyclic compounds with working memory enhancing activity Red Bull GmbH (AT) 2016-02-17 — — EP claimed
US-20210380545-A1 (S)-ENANTIOMERIC FORM OF A HETEROCYCLIC COMPOUND HAVING MOTIVATION IMPROVING AND/OR REFERENCE MEMORY ENHANCING ACTIVITY RED BULL GMBH (AT) 2021-12-09 — — US disclosed
WO-2021048284-A1 THIAZOLE AND DIPHENYL SUBSTITUTED SULFOXIDES FOR USE IN IMPROVING COGNITION FUNCTIONS AND AGAINST ADDICTIONS TO SUBSTANCES RED BULL GMBH (AT) 2021-03-18 — — WO disclosed
US-10221147-B2 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2019-03-05 — — US disclosed
US-10221147-B2 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2019-03-05 — — US disclosed
EP-2985279-B1 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2017-08-02 — — EP disclosed
US-20170174642-A1 HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY COGMOTIV FLEXCO (AT) 2017-06-22 — — US disclosed
WO-2016023997-A1 HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY RED BULL GMBH (AT) 2016-02-18 — — WO disclosed
EP-2985279-A1 Heterocyclic compounds with working memory enhancing activity Red Bull GmbH (AT) 2016-02-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174642-A1 HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY TAAR1, ACHE, RIF1 SLC6A3 683/4885KDM1A 752/4885MAOB 411/4885
US-20210380545-A1 (S)-ENANTIOMERIC FORM OF A HETEROCYCLIC COMPOUND HAVING MOTIVATION IMPROVING AND/OR REFERENCE MEMORY ENHANCING ACTIVITY TFEB, TAAR1, RABGGTB SLC6A3 444/4885KDM1A 1527/4885MAOB 85/4885
US-10221147-B2 Heterocyclic compounds with working memory enhancing activity TAAR1, ACHE, RIF1 SLC6A3 683/4885KDM1A 752/4885MAOB 411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback